AT387774B - Verfahren zur herstellung von neuen 1,2,4-triazol-derivaten - Google Patents
Verfahren zur herstellung von neuen 1,2,4-triazol-derivatenInfo
- Publication number
- AT387774B AT387774B AT0151084A AT151084A AT387774B AT 387774 B AT387774 B AT 387774B AT 0151084 A AT0151084 A AT 0151084A AT 151084 A AT151084 A AT 151084A AT 387774 B AT387774 B AT 387774B
- Authority
- AT
- Austria
- Prior art keywords
- triazole derivatives
- producing new
- producing
- new
- triazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8006806 | 1980-02-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA151084A ATA151084A (de) | 1988-08-15 |
| AT387774B true AT387774B (de) | 1989-03-10 |
Family
ID=10511754
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0093981A AT380240B (de) | 1980-02-28 | 1981-02-27 | Verfahren zur herstellung von neuen heterocyclischen verbindungen |
| AT0151084A AT387774B (de) | 1980-02-28 | 1984-05-08 | Verfahren zur herstellung von neuen 1,2,4-triazol-derivaten |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0093981A AT380240B (de) | 1980-02-28 | 1981-02-27 | Verfahren zur herstellung von neuen heterocyclischen verbindungen |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4670448A (de) |
| JP (2) | JPS56147777A (de) |
| KR (3) | KR850000668B1 (de) |
| AT (2) | AT380240B (de) |
| AU (1) | AU544357B2 (de) |
| BE (1) | BE887730A (de) |
| CA (1) | CA1158649A (de) |
| CH (1) | CH655104A5 (de) |
| CY (1) | CY1335A (de) |
| DE (1) | DE3107628A1 (de) |
| DK (1) | DK90681A (de) |
| ES (4) | ES499931A0 (de) |
| FI (1) | FI76076C (de) |
| FR (1) | FR2477150A1 (de) |
| GB (1) | GB2075007B (de) |
| HK (1) | HK69186A (de) |
| IE (1) | IE50987B1 (de) |
| IL (1) | IL62229A (de) |
| IT (1) | IT1209846B (de) |
| KE (1) | KE3629A (de) |
| MY (1) | MY8500428A (de) |
| NL (2) | NL186812C (de) |
| NO (1) | NO810681L (de) |
| NZ (1) | NZ196365A (de) |
| SE (1) | SE448233B (de) |
| ZA (1) | ZA811331B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57169452A (en) * | 1981-04-14 | 1982-10-19 | Teikoku Hormone Mfg Co Ltd | Novel phenoxyalkylamide derivative |
| AU8480982A (en) * | 1981-06-11 | 1983-01-13 | Glaxo Group Limited | 1,2,4-triazole derivatives with histamine h2-blocking activity |
| PT76280A (en) * | 1982-02-24 | 1983-03-01 | Glaxo Group Ltd | Process for preparing heterocyclic derivatives |
| CA1189508A (en) * | 1982-02-25 | 1985-06-25 | Roger Hayes | Heterocyclic derivatives as histamine h.sub.2- antagonists |
| GB8417194D0 (en) * | 1984-07-05 | 1984-08-08 | Boots Co Plc | Therapeutic agents |
| GB8628475D0 (en) * | 1986-11-28 | 1987-01-07 | Glaxo Group Ltd | Medicaments |
| GB8805268D0 (en) * | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
| JP3328082B2 (ja) * | 1994-12-13 | 2002-09-24 | 日本カーバイド工業株式会社 | Ｎ−グアニジノチオ尿素塩及び３−アミノ−５−メルカプト−１，２，４−トリアゾールの製造方法 |
| WO2001024796A1 (en) * | 1999-10-01 | 2001-04-12 | Smithkline Beecham Corporation | 1,2,4-triazole derivatives, composition, process of making and methods of use |
| JP4564786B2 (ja) * | 2004-06-07 | 2010-10-20 | 株式会社日本ファインケム | １−置換―１―アミノグアニジン又はその塩、及びこれらの製造方法 |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
| DE2835695A1 (de) * | 1977-08-29 | 1979-03-15 | Yamanouchi Pharma Co Ltd | Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten |
| GB2023133B (en) * | 1978-04-26 | 1982-09-08 | Glaxo Group Ltd | Heterocyclic derivatives |
| AR228941A1 (es) * | 1978-04-26 | 1983-05-13 | Glaxo Group Ltd | Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos |
| DK89480A (da) * | 1979-03-02 | 1980-09-03 | Glaxo Group Ltd | R fremgangsmaade til fremstilling af heterocycliske forbindelse |
-
1981
- 1981-02-26 CH CH1288/81A patent/CH655104A5/fr not_active IP Right Cessation
- 1981-02-26 FR FR8103847A patent/FR2477150A1/fr active Granted
- 1981-02-27 SE SE8101311A patent/SE448233B/sv not_active IP Right Cessation
- 1981-02-27 NZ NZ196365A patent/NZ196365A/en unknown
- 1981-02-27 IL IL62229A patent/IL62229A/xx unknown
- 1981-02-27 DE DE19813107628 patent/DE3107628A1/de active Granted
- 1981-02-27 DK DK90681A patent/DK90681A/da not_active Application Discontinuation
- 1981-02-27 ZA ZA00811331A patent/ZA811331B/xx unknown
- 1981-02-27 ES ES499931A patent/ES499931A0/es active Granted
- 1981-02-27 IE IE431/81A patent/IE50987B1/en unknown
- 1981-02-27 NO NO810681A patent/NO810681L/no unknown
- 1981-02-27 CY CY133581A patent/CY1335A/xx unknown
- 1981-02-27 CA CA000371889A patent/CA1158649A/en not_active Expired
- 1981-02-27 IT IT8147905A patent/IT1209846B/it active
- 1981-02-27 FI FI810619A patent/FI76076C/fi not_active IP Right Cessation
- 1981-02-27 AT AT0093981A patent/AT380240B/de not_active IP Right Cessation
- 1981-02-27 AU AU67933/81A patent/AU544357B2/en not_active Ceased
- 1981-02-27 GB GB8106314A patent/GB2075007B/en not_active Expired
- 1981-02-27 NL NLAANVRAGE8100979,A patent/NL186812C/xx not_active IP Right Cessation
- 1981-02-27 BE BE0/203963A patent/BE887730A/fr unknown
- 1981-02-28 JP JP2929381A patent/JPS56147777A/ja active Granted
- 1981-02-28 KR KR1019810000669A patent/KR850000668B1/ko active
-
1982
- 1982-02-16 ES ES509669A patent/ES509669A0/es active Granted
- 1982-12-16 ES ES518305A patent/ES8405775A1/es not_active Expired
-
1983
- 1983-02-10 US US06/465,616 patent/US4670448A/en not_active Expired - Fee Related
-
1984
- 1984-03-16 ES ES530741A patent/ES8506292A1/es not_active Expired
- 1984-05-08 AT AT0151084A patent/AT387774B/de not_active IP Right Cessation
- 1984-08-18 KR KR1019840004976A patent/KR850000682B1/ko not_active IP Right Cessation
- 1984-08-20 KR KR1019840004977A patent/KR850000676B1/ko not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY428/85A patent/MY8500428A/xx unknown
-
1986
- 1986-04-16 KE KE3629A patent/KE3629A/xx unknown
- 1986-09-18 HK HK691/86A patent/HK69186A/xx unknown
-
1988
- 1988-02-29 JP JP63047352A patent/JPS6452763A/ja active Pending
- 1988-09-09 NL NL8802221A patent/NL8802221A/nl not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT378768B (de) | Verfahren zur herstellung von neuen 1-sulfo-2-oxoazetidin-derivaten | |
| AT376212B (de) | Verfahren zur herstellung von neuen 1,2,4-triazolderivaten | |
| AT381091B (de) | Verfahren zur herstellung von neuen ergolinderivaten | |
| AT387774B (de) | Verfahren zur herstellung von neuen 1,2,4-triazol-derivaten | |
| AT376654B (de) | Verfahren zur herstellung von neuen 1-phenyl-2cyclohexen-1-alkylamin-derivaten | |
| AT378957B (de) | Verfahren zur herstellung von neuen triazolderivaten | |
| AT379388B (de) | Verfahren zur herstellung von neuen 4-chinolonderivaten | |
| AT365588B (de) | Verfahren zur herstellung von neuen spiropyridochroman-4',5-hydantoinen | |
| AT380477B (de) | Verfahren zur herstellung von neuen spirothiazolidindion-derivaten | |
| AT375076B (de) | Verfahren zur herstellung von neuen ergolinderivaten | |
| AT374203B (de) | Verfahren zur herstellung von neuen 2'-desoxy-3', 5'-di-o-alkylcarbonyl-5-fluoruridinderivaten | |
| AT380233B (de) | Verfahren zur herstellung von neuen 1,7,7 | |
| AT369736B (de) | Verfahren zur herstellung von 1,2,4-triazol | |
| AT374451B (de) | Verfahren zur herstellung von neuen benzylidenderivaten | |
| AT373891B (de) | Verfahren zur herstellung von neuen rifamycinderivaten | |
| AT381318B (de) | Verfahren zur herstellung von neuen nitrosoharnstoffderivaten | |
| AT377264B (de) | Verfahren zur herstellung von neuen nitrosoharnstoffderivaten | |
| AT381940B (de) | Verfahren zur herstellung von neuen ergolinderivaten | |
| AT373890B (de) | Verfahren zur herstellung von neuen 1,4;3,6-dianhydro-2,5-diazido-2,5-didesoxy-hexit-derivaten | |
| AT389109B (de) | Verfahren zur herstellung von dihydroaryloxyalkylamino-1,2,4-triazol-derivate | |
| ATA127983A (de) | Verfahren zur herstellung von neuen 1,1,4-triazolderivaten | |
| ATA80583A (de) | Verfahren zur herstellung von neuen 1,2,4-triazolderivaten | |
| AT367758B (de) | Verfahren zur herstellung von neuen 20-methyl-13, 14-didehydro-pgi 2-derivaten | |
| AT378195B (de) | Verfahren zur herstellung von neuen ergopeptinderivaten | |
| AT374482B (de) | Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |